Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing

PLoS Genetics

Volumn 8, Issue 5, 2012, Pages

  Pradeepa, Madapura M ^a   Sutherland, Heidi G ^a   Ule, Jernej ^b   Grimes, Graeme R ^a   Bickmore, Wendy A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; LENS EPITHELIUM DERIVED GROWTH FACTOR; PROTEIN P52; PROTEIN SRSF1; REGULATOR PROTEIN; UNCLASSIFIED DRUG; HISTONE; ISOPROTEIN; NUCLEAR PROTEIN; PSIP1 PROTEIN, HUMAN; RNA BINDING PROTEIN; SERINE ARGININE RICH SPLICING PROTEINS; SERINE-ARGININE-RICH SPLICING PROTEINS; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CHROMATIN; CONTROLLED STUDY; EMBRYO; HISTONE METHYLATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA PROCESSING; ANIMAL; CELL STRAIN 3T3; CYTOLOGY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHYLATION; PROTEIN TERTIARY STRUCTURE;

3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; ANIMALS; CHROMATIN; FIBROBLASTS; GENE EXPRESSION REGULATION; HISTONES; METHYLATION; MICE; NUCLEAR PROTEINS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS;

EID: 84863654457     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002717     Document Type: Article

References (79)

1. Listerman I, Sapra AK, Neugebauer KM, (2006) Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells. Nat Struct Mol Biol 13: 815-822.
2. Cramer P, Pesce CG, Baralle FE, Kornblihtt AR, (1997) Functional association between promoter structure and transcript alternative splicing. Proc Natl Acad Sci U S A 94: 11456-11460.
3. Cramer P, Caceres JF, Cazalla D, Kadener S, Muro AF, et al. (1999) Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell 4: 251-258.
4. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T, (2011) Epigenetics in alternative pre-mRNA splicing. Cell 144: 16-26.
5. Gunderson FQ, Johnson TL, (2009) Acetylation by the transcriptional coactivator Gcn5 plays a novel role in co-transcriptional spliceosome assembly. PLoS Genet 5: e1000682 doi:10.1371/journal.pgen.1000682.
6. Martinez E, Palhan VB, Tjernberg A, Lymar ES, Gamper AM, et al. (2001) Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol Cell Biol 21: 6782-6795.
7. Sims RJ III, Millhouse S, Chen CF, Lewis BA, Erdjument-Bromage H, et al. (2007) Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol Cell 28: 665-676.
8. de la Mata M, Alonso CR, Kadener S, Fededa JP, Blaustein M, et al. (2003) A slow RNA polymerase II affects alternative splicing in vivo. Mol Cell 12: 525-532.
9. Kadener S, Fededa JP, Rosbash M, Kornblihtt AR, (2002) Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation. Proc Natl Acad Sci U S A 99: 8185-8190.
10. de la Mata M, Lafaille C, Kornblihtt AR, (2010) First come, first served revisited: factors affecting the same alternative splicing event have different effects on the relative rates of intron removal. RNA 16: 904-912.
11. Schor IE, Rascovan N, Pelisch F, Allo M, Kornblihtt AR, (2009) Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing. Proc Natl Acad Sci U S A 106: 4325-4330.
12. Saint-Andre V, Batsche E, Rachez C, Muchardt C, (2011) Histone H3 lysine 9 trimethylation and HP1gamma favor inclusion of alternative exons. Nat Struct Mol Biol 18: 337-344.
13. Hon G, Wang W, Ren B, (2009) Discovery and annotation of functional chromatin signatures in the human genome. PLoS Comput Biol 5: e1000566 doi:10.1371/journal.pcbi.1000566.
14. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, et al. (2009) Differential chromatin marking of introns and expressed exons by H3K36me3. Nat Genet 41: 376-381.
15. Spies N, Nielsen CB, Padgett RA, Burge CB, (2009) Biased chromatin signatures around polyadenylation sites and exons. Mol Cell 36: 245-254.
16. Andersson R, Enroth S, Rada-Iglesias A, Wadelius C, Komorowski J, (2009) Nucleosomes are well positioned in exons and carry characteristic histone modifications. Genome Res 19: 1732-1741.
17. Dhami P, Saffrey P, Bruce AW, Dillon SC, Chiang K, et al. (2010) Complex exon-intron marking by histone modifications is not determined solely by nucleosome distribution. PLoS ONE 5: e12339 doi:10.1371/journal.pone.0012339.
18. Kim S, Kim H, Fong N, Erickson B, Bentley DL, (2011) Pre-mRNA splicing is a determinant of histone H3K36 methylation. Proc Natl Acad Sci U S A.
19. de Almeida SF, Grosso AR, Koch F, Fenouil R, Carvalho S, et al. (2011) Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36. Nat Struct Mol Biol.
20. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, et al. (2010) Regulation of alternative splicing by histone modifications. Science 327: 996-1000.
21. Ge H, Si Y, Roeder RG, (1998) Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J 17: 6723-6729.
22. Sutherland HG, Newton K, Brownstein DG, Holmes MC, Kress C, et al. (2006) Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations. Mol Cell Biol 26: 7201-7210.
23. Hombrouck A, De Rijck J, Hendrix J, Vandekerckhove L, Voet A, et al. (2007) Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV. PLoS Pathog 3: e47 doi:10.1371/journal.ppat.0030047.
24. Marshall HM, Ronen K, Berry C, Llano M, Sutherland H, et al. (2007) Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS ONE 2: e1340 doi:10.1371/journal.pone.0001340.
25. Shun MC, Raghavendra NK, Vandegraaff N, Daigle JE, Hughes S, et al. (2007) LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev 21: 1767-1778.
26. Engelman A, Cherepanov P, (2008) The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS Pathog 4: e1000046 doi:10.1371/journal.ppat.1000046.
27. Singh DP, Kimura A, Chylack LT Jr, Shinohara T, (2000) Lens epithelium-derived growth factor (LEDGF/p75) and p52 are derived from a single gene by alternative splicing. Gene 242: 265-273.
28. Llano M, Delgado S, Vanegas M, Poeschla EM, (2004) Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J Biol Chem 279: 55570-55577.
29. Vanegas M, Llano M, Delgado S, Thompson D, Peretz M, et al. (2005) Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J Cell Sci 118: 1733-1743.
30. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, et al. (2003) LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 278: 33528-33539.
31. Cherepanov P, Devroe E, Silver PA, Engelman A, (2004) Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase. J Biol Chem 279: 48883-48892.
32. Cherepanov P, Ambrosio AL, Rahman S, Ellenberger T, Engelman A, (2005) Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc Natl Acad Sci U S A 102: 17308-17313.
33. Llano M, Vanegas M, Fregoso O, Saenz D, Chung S, et al. (2004) LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J Virol 78: 9524-9537.
34. Bartholomeeusen K, De Rijck J, Busschots K, Desender L, Gijsbers R, et al. (2007) Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75. J Mol Biol 372: 407-421.
35. Maertens GN, Cherepanov P, Engelman A, (2006) Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin. J Cell Sci 119: 2563-2571.
36. Yokoyama A, Cleary ML, (2008) Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14: 36-46.
37. Ge H, Roeder RG, (1994) Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes. Cell 78: 513-523.
38. Ge H, Si Y, Wolffe AP, (1998) A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. Mol Cell 2: 751-759.
39. Cherepanov P, Maertens G, Proost P, Devreese B, Van Beeumen J, et al. (2003) HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 278: 372-381.
40. Sutherland HG, Mumford GK, Newton K, Ford LV, Farrall R, et al. (2001) Large-scale identification of mammalian proteins localized to nuclear sub-compartments. Hum Mol Genet 10: 1995-2011.
41. Shun MC, Botbol Y, Li X, Di Nunzio F, Daigle JE, et al. (2008) Identification and characterization of PWWP domain residues critical for LEDGF/p75 chromatin binding and human immunodeficiency virus type 1 infectivity. J Virol 82: 11555-11567.
42. Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, et al. (2003) The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 28: 69-74.
43. Vezzoli A, Bonadies N, Allen MD, Freund SM, Santiveri CM, et al. (2010) Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. Nat Struct Mol Biol 17: 617-619.
44. Dhayalan A, Rajavelu A, Rathert P, Tamas R, Jurkowska RZ, et al. (2010) The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J Biol Chem 285: 26114-26120.
45. Vermeulen M, Eberl HC, Matarese F, Marks H, Denissov S, et al. (2010) Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 142: 967-980.
46. Long JC, Caceres JF, (2009) The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417: 15-27.
47. Misteli T, Caceres JF, Clement JQ, Krainer AR, Wilkinson MF, et al. (1998) Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J Cell Biol 143: 297-307.
48. Stamm S, (2008) Regulation of alternative splicing by reversible protein phosphorylation. J Biol Chem 283: 1223-1227.
49. Cazalla D, Zhu J, Manche L, Huber E, Krainer AR, et al. (2002) Nuclear export and retention signals in the RS domain of SR proteins. Mol Cell Biol 22: 6871-6882.
50. Loomis RJ, Naoe Y, Parker JB, Savic V, Bozovsky MR, et al. (2009) Chromatin binding of SRp20 and ASF/SF2 and dissociation from mitotic chromosomes is modulated by histone H3 serine 10 phosphorylation. Mol Cell 33: 450-461.
51. Huang S, Spector DL, (1991) Nascent pre-mRNA transcripts are associated with nuclear regions enriched in splicing factors. Genes Dev 5: 2288-2302.
52. Konig J, Zarnack K, Rot G, Curk T, Kayikci M, et al. (2010) iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol 17: 909-915.
53. Ule J, Ule A, Spencer J, Williams A, Hu JS, et al. (2005) Nova regulates brain-specific splicing to shape the synapse. Nat Genet 37: 844-852.
54. Wang Z, Kayikci M, Briese M, Zarnack K, Luscombe NM, et al. (2010) iCLIP predicts the dual splicing effects of TIA-RNA interactions. PLoS Biol 8: e1000530 doi:10.1371/journal.pbio.1000530.
55. Han J, Ding JH, Byeon CW, Kim JH, Hertel KJ, et al. (2011) SR proteins induce alternative exon skipping through their activities on the flanking constitutive exons. Mol Cell Biol 31: 793-802.
56. Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, et al. (1995) Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81: 391-401.
57. Englert C, (1998) WT1-more than a transcription factor? Trends Biochem Sci 23: 389-393.
58. Davies RC, Calvio C, Bratt E, Larsson SH, Lamond AI, et al. (1998) WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes Dev 12: 3217-3225.
59. Schwartz S, Ast G, (2010) Chromatin density and splicing destiny: on the cross-talk between chromatin structure and splicing. EMBO J 29: 1629-1636.
60. Zhang P, Du J, Sun B, Dong X, Xu G, et al. (2006) Structure of human MRG15 chromo domain and its binding to Lys36-methylated histone H3. Nucleic Acids Res 34: 6621-6628.
61. Kornblihtt AR, (2006) Chromatin, transcript elongation and alternative splicing. Nat Struct Mol Biol 13: 5-7.
62. Sims RJ III, Chen CF, Santos-Rosa H, Kouzarides T, Patel SS, et al. (2005) Human but not yeast CHD1 binds directly and selectively to histone H3 methylated at lysine 4 via its tandem chromodomains. J Biol Chem 280: 41789-41792.
63. Flanagan JF, Mi LZ, Chruszcz M, Cymborowski M, Clines KL, et al. (2005) Double chromodomains cooperate to recognize the methylated histone H3 tail. Nature 438: 1181-1185.
64. Zahler AM, Neugebauer KM, Lane WS, Roth MB, (1993) Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260: 219-222.
65. Hanamura A, Caceres JF, Mayeda A, Franza BR Jr, Krainer AR, (1998) Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4: 430-444.
66. Yassin ER, Abdul-Nabi AM, Takeda A, Yaseen NR, (2010) Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif. Leukemia 24: 1001-1011.
67. Hussey DJ, Moore S, Nicola M, Dobrovic A, (2001) Fusion of the NUP98 gene with the LEDGF/p52 gene defines a recurrent acute myeloid leukemia translocation. BMC Genet 2: 20.
68. Grand FH, Koduru P, Cross NC, Allen SL, (2005) NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemia. Leuk Res 29: 1469-1472.
69. Ahuja HG, Hong J, Aplan PD, Tcheurekdjian L, Forman SJ, et al. (2000) t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epithelium-derived growth factor (LEDGF). Cancer Res 60: 6227-6229.
70. Wang GG, Cai L, Pasillas MP, Kamps MP, (2007) NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 9: 804-812.
71. Xu S, Powers MA, (2009) Nuclear pore proteins and cancer. Semin Cell Dev Biol 20: 620-630.
72. Johnson DS, Mortazavi A, Myers RM, Wold B, (2007) Genome-wide mapping of in vivo protein-DNA interactions. Science 316: 1497-1502.
73. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
74. Efron B, (2007) Correlation and Large-Scale Simultaneous Significance Testing. Jour Amer Stat Assoc 102: 99-103.
75. Peng S, Kuroda MI, Park PJ, (2010) Quantized correlation coefficient for measuring reproducibility of ChIP-chip data. BMC Bioinformatics 11: 399.
76. Toedling J, Skylar O, Krueger T, Fischer JJ, Sperling S, et al. (2007) Ringo-an R/Bioconductor package for analyzing ChIP-chip readouts. BMC Bioinformatics 8: 221.
77. Wright KJ, Marr MT, Tjian R, (2006) TAF4 nucleates a core subcomplex of TFIID and mediates activated transcription from a TATA-less promoter. Proc Natl Acad Sci U S A 103: 12347-12352.
78. Cazalla D, Sanford JR, Caceres JF, (2005) A rapid and efficient protocol to purify biologically active recombinant proteins from mammalian cells. Protein Expr Purif 42: 54-58.
79. Briers S, Crawford C, Bickmore WA, Sutherland HG, (2009) KRAB zinc-finger proteins localise to novel KAP1-containing foci that are adjacent to PML nuclear bodies. J Cell Sci 122: 937-946.